Plasma apoptotic-body lipids in physiological aging: an abstract lipidomics study
In this abstract, plasma apoptotic bodies (ApoEVs) from physiologically aging people showed lower total lipids, several lipid subclasses and fatty acid saturation; the authors propose these as candidate aging biomarkers. [1]
Automatic summary · not editorially reviewed
The key findings
The abstract proposes plasma apoptotic bodies as potential sensitive biomarkers of aging status, but says this remains to be explored. [1]
The authors report lower total levels of Hex2Cer, LPC, LPE, TG, ChE, SM and SPH as features of aging. [1]
The authors say the study offers circulating lipid biomarkers for assessing biological aging and age-related pathologies. [1]
The source at a glance
- Study type / format
- Abstract of a lipidomics study of plasma apoptotic extracellular vesicles
- Population / context
- People undergoing physiological aging, as described in the abstract; no further details given.
- Summary based on
- Study abstract
- Original publication
- September 30, 2026
Aging and plasma apoptotic-body lipids
The abstract frames aging as linked to chronic disease, degenerative conditions and mortality. Apoptotic bodies are described as direct products of apoptotic cells that may reflect apoptotic activity and the degree of aging. The authors say such bodies could be sensitive biomarkers of aging status, but note this remains to be explored.
Supporting source [1]
Lipid classes lower in aging ApoEVs
The authors analyzed total lipids, multiple lipid subclasses and fatty acid saturation in plasma apoptotic bodies to find aging-associated changes. They report a comprehensive reduction in total lipids, several lipid subclasses and fatty acid saturation, described as systemic lipid reprogramming in aging. Lower total levels of Hex2Cer, LPC, LPE, TG, ChE, SM and SPH are named as features of aging.
Supporting source [1]
Proposed biomarkers, not proven causes
The authors say the work deepens understanding of aging-related lipid dysfunction and offers circulating lipid biomarkers for assessing biological aging and age-related pathologies. These are associations in an abstract; the text does not show that the lipid changes cause aging or disease. The abstract does not report sample size, age range, comparison groups or follow-up.
Supporting source [1]
How to interpret this
Abstract only; the full text was not reviewed. The abstract does not report sample size, age range, comparison groups, follow-up or effect sizes, and the lipid findings are associations, not evidence of cause.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Li M, Huang H, Tang Q. · europepmc.org · September 30, 2026